Biofrontera (B8FK.DE) Stock Price
Biofrontera Price
Revenue has compounded at 26.7% per year over the past 19 years to 13.19 M EUR. Biofrontera's net margin stands at -30.1%, down from 131.1% several years earlier.
Biofrontera stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Biofrontera business model & stock analysis
Frequently asked questions about Biofrontera
7 analysts currently rate the Biofrontera stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Biofrontera to generate revenue of 71.40 M EUR and earnings per share of 2.19 EUR.
The Biofrontera share (B8FK.DE) is listed on 8 stock exchanges, including: London (0DOL.L), SIX (Zürich) (B8F.SW), XETRA (B8F.DE), Frankfurt (B8F.F), München (B8F.MU), Düsseldorf (B8F.DU), Hamburg (B8F.HM).
The expected revenue of Biofrontera is 71.40 M EUR. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Biofrontera is 13.35 M EUR. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Biofrontera is currently 1.38. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Biofrontera stock.
The price-to-sales ratio (P/S) of Biofrontera is currently 0.26. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Biofrontera stock.
The Eulerpool Quality Score for Biofrontera is 2/10.
The ISIN of Biofrontera is DE000A4BGGM7. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Biofrontera is 604611. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Biofrontera is B8FK.DE. The ticker symbol is used to trade Biofrontera shares on the stock exchange.
Biofrontera stock
Biofrontera Peer Group
Biofrontera Ticker
All fundamentals and in-depth analysis of Biofrontera
Our stock analysis for Biofrontera stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biofrontera. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.